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Objective
The aim of this study was to assess the impact of left
ventricular hypertrophy, myocardial fibrosis, myocardial
perfusion reserve (MPR) and diastolic dysfunction on
objectively measured aerobic exercise capacity (peak
VO2) in severe aortic stenosis (AS).
Background
The management of asymptomatic patients with
severe AS remains controversial and clinical practice
varies. Echocardiographic measures of severity do not
discriminate between symptomatic status or predict
exercise capacity. The purpose of this study was to
investigate the mechanisms contributing to symptom
generation and exercise intolerance. This needs to be
fully understood to optimise the management of
asymptomatic AS.
Methods
Patients were prospectively enrolled from a single car-
diac surgical centre. Inclusion criteria: age 18-85, iso-
lated severe AS referred for valve replacement.
Exclusion criteria: syncope; other moderate/severe
valve disease, previous valve surgery, obstructive cor-
onary artery disease (>50% luminal stenosis on invasive
angiography), chronic obstructive pulmonary disease,
atrial fibrillation, estimated glomerular filtration rate
<30mL/min. Investigations and primary outcome mea-
sures; cardiac magnetic resonance (CMR) - left ventri-
cular mass index (LVMI), MPR (calculated from
absolute myocardial blood flow during adenosine
hyperaemia and rest determined by model-independent
deconvolution of signal intensity curves with an arter-
ial input function), late gadolinium enhancement
(LGE); echocardiography - AS severity, tissue Doppler-
derived diastolic function; symptom-limited bicycle
ergometer cardiopulmonary exercise testing (CPEX) -
peak VO2. Linear regression investigated possible pre-
dictors of continuous outcome measures. Stepwise
selection methods were used to determine the most
important predictors of outcome.
Results
Four patients with variable LVMI, LGE and MPR are
shown, Figure 1. Univariate analyses and results from
the stepwise model selection for peak VO2 are sum-
marised in Table 1. Only MPR was of independent sig-
nificance in predicting age and sex corrected peak VO2.
The relationship between peak VO2 and MPR is shown,
Figure 2. Patients with higher NYHA Class had lower
MPR (p=0.001). Examining predictors of MPR the best
stepwise model contained LVMI and LGE category as
independent predictors, Table 2.
Conclusions
MPR is a novel independent predictor of peak VO2 and
is inversely related to NYHA functional class in severe
AS. Microvascular dysfunction is determined by a com-
bination of factors including AS severity, LVMI, diastolic
perfusion time, myocardial fibrosis and LV filling pres-
sure. Further work is required to determine the clinical
significance of microvascular dysfunction in AS.
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Figure 1 Patients (A-D). i) Short-axis cine end-diastole; ii) LGE - white arrows; Perfusion imaging mid-LV slice iii) hyperaemia, iv) rest.
Table 1 Predictors of Peak VO2
Variable Univariate
b
p-value Stepwise
model b
p-value
Sex -0.41 0.005 -0.436 0.002
Age -0.32 0.03 -0.154 0.248
Peak aortic velocity -0.18 0.24 na na
Aortic valve area index 0.04 0.79 na na
Septal E/E’ -0.35 0.01 na na
LV mass index 0.03 0.85 na na
LV ejection fraction -0.02 0.91 na na
Late gadolinium
enhancement
-0.023 0.517 na na
Myocardial perfusion
reserve
0.45 0.004 0.457 0.001
Table 2 Predictors of Perfusion Reserve
Variable Univariate
b
p-value Stepwise
model b
p-value
Sex 0.38 0.023 na na
Age -0.093 0.538 na na
Diastolic perfusion time -0.399 0.01 na na
Peak aortic velocity -0.339 0.02 na na
Aortic valve area index 0.209 0.172 na na
LV mass index -0.516 <0.001 -0.403 0.004
LV ejection fraction 0.259 0.086 na na
Late gadolinium
enhancement
-0.456 0.002 -0.306 0.025
Septal E/E’ -0.312 0.041 na na
Figure 2 Peak VO2 and MPR.
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